Intragraft cytomegalovirus infection: results of randomized trial of valacyclovir prophylaxis vs. preemptive valganciclovir therapy in renal transplant recipients

Abstrakt

Intragraft cytomegalovirus infection: results of randomized trial of valacyclovir prophylaxis vs. preemptive valganciclovir therapy in renal transplant recipients.

Klíčová slova

• cytomegalovirus (CMV)
• intragraft CMV infection
• prophylaxis